![\"Zequan](\"https:\/\/med.virginia.edu\/tcv-lab\/wp-content\/uploads\/sites\/460\/2025\/02\/Yang_3-4.jpg\")
<\/div>Zequan Yang, MD<\/b>
\nAssociate Professor of Surgery
\n<\/em>As a clinician, Dr. Yang specializes in acute care surgery, trauma and surgical intensive care. As a scientist, his research has focused in the areas of myocardial and lung ischemia-reperfusion (IRI) for >20 years and septic shock for >10 years. His research utilizes small and large animal models of acute myocardial IRI, post-infarct LV remodeling, and sepsis. MRI is used to evaluate mouse myocardial infarct size and cardiac function. He has recently reported the novel finding of a cardiac-splenic axis that mediates inflammatory responses that exacerbate myocardial infarct and post-MI LV remodeling, as documented in several publications. He also laid the groundwork for utilizing topical neck cooling to attenuate inflammatory responses and preserve organ function during severe intra-abdominal sepsis in both murine and porcine models. Dr. Yang trains surgery residents both in the operating room as well as in laboratory research. As a PI on our NIH-funded R01, he helps guide all of our research studies focused on perfusion-based methods to treat acute lung injury. Dr. Yang is also a PI on our T32 Research Training Program for surgery residents in cardiovascular surgery.<\/div>
\nAssociate Professor of Surgery
\n<\/em>As a clinician, Dr. Yang specializes in acute care surgery, trauma and surgical intensive care. As a scientist, his research has focused in the areas of myocardial and lung ischemia-reperfusion (IRI) for >20 years and septic shock for >10 years. His research utilizes small and large animal models of acute myocardial IRI, post-infarct LV remodeling, and sepsis. MRI is used to evaluate mouse myocardial infarct size and cardiac function. He has recently reported the novel finding of a cardiac-splenic axis that mediates inflammatory responses that exacerbate myocardial infarct and post-MI LV remodeling, as documented in several publications. He also laid the groundwork for utilizing topical neck cooling to attenuate inflammatory responses and preserve organ function during severe intra-abdominal sepsis in both murine and porcine models. Dr. Yang trains surgery residents both in the operating room as well as in laboratory research. As a PI on our NIH-funded R01, he helps guide all of our research studies focused on perfusion-based methods to treat acute lung injury. Dr. Yang is also a PI on our T32 Research Training Program for surgery residents in cardiovascular surgery.<\/div>
<\/div><\/p>\n
\n![\"I](\"https:\/\/med.virginia.edu\/tcv-lab\/wp-content\/uploads\/sites\/460\/2024\/11\/Kron_photo.jpg\")
<\/div>
\n
<\/div><\/b>Irving Kron, MD<\/b>
\nProfessor of Surgery Emeritus<\/em>
\nIn 1993, Dr. Kron was named Chief of the Division of Thoracic and Cardiovascular Surgery at UVA and became the Program Director of the Thoracic Residency program. Dr. Kron helped increase the national visibility of the Division and the Thoracic Residency program at UVA. He was Chair of the Department of Surgery from 2002 – 2017. He developed a successful NIH-funded research laboratory where many residents and students have gained experience in thoracic surgical research. He is a PI on our NIH-funded research into lung ischemia-reperfusion injury and perfusion-based methods to treat ARDS as well as PI on our NHLBI-funded T32 Research Training Program for surgery residents in cardiovascular surgery.<\/div>
\nProfessor of Surgery Emeritus<\/em>
\nIn 1993, Dr. Kron was named Chief of the Division of Thoracic and Cardiovascular Surgery at UVA and became the Program Director of the Thoracic Residency program. Dr. Kron helped increase the national visibility of the Division and the Thoracic Residency program at UVA. He was Chair of the Department of Surgery from 2002 – 2017. He developed a successful NIH-funded research laboratory where many residents and students have gained experience in thoracic surgical research. He is a PI on our NIH-funded research into lung ischemia-reperfusion injury and perfusion-based methods to treat ARDS as well as PI on our NHLBI-funded T32 Research Training Program for surgery residents in cardiovascular surgery.<\/div>
<\/div><\/p>\n
\n
\n
<\/div>![\"Victor](\"https:\/\/med.virginia.edu\/tcv-lab\/wp-content\/uploads\/sites\/460\/2025\/02\/Laubach_Emeritus2.jpg\")
<\/div>
<\/div><\/b><\/b>Victor Laubach, PhD<\/b>
\nProfessor of Surgery Emeritus<\/em>
\nEmail<\/strong>:\u00a0 laubach@virginia.edu
\nDr. Laubach received a Ph.D. in Genetics from the George Washington University. His graduate research was conducted in the Pulmonary Branch of the NHLBI, Bethesda, MD, where he studied alpha-1-antitrypsin deficiency. Dr. Laubach then did postdoctoral research at Glaxo Wellcome Pharmaceuticals in Research Triangle Park, NC to study nitric oxide biology. In 1996 Dr. Laubach came to the UVA Department of Surgery where he directs laboratory research in discovering mechanisms of lung ischemia-reperfusion injury (IRI) after transplant and in perfusion-based methods to treat severe ARDS (via in vivo lung perfusion, IVLP) or prevent IRI (via ex vivo lung perfusion, EVLP). He is a PI on our NIH-funded research and PI on our NHLBI-funded T32 Research Training Program for surgery residents in cardiovascular surgery.<\/div>
\nProfessor of Surgery Emeritus<\/em>
\nEmail<\/strong>:\u00a0 laubach@virginia.edu
\nDr. Laubach received a Ph.D. in Genetics from the George Washington University. His graduate research was conducted in the Pulmonary Branch of the NHLBI, Bethesda, MD, where he studied alpha-1-antitrypsin deficiency. Dr. Laubach then did postdoctoral research at Glaxo Wellcome Pharmaceuticals in Research Triangle Park, NC to study nitric oxide biology. In 1996 Dr. Laubach came to the UVA Department of Surgery where he directs laboratory research in discovering mechanisms of lung ischemia-reperfusion injury (IRI) after transplant and in perfusion-based methods to treat severe ARDS (via in vivo lung perfusion, IVLP) or prevent IRI (via ex vivo lung perfusion, EVLP). He is a PI on our NIH-funded research and PI on our NHLBI-funded T32 Research Training Program for surgery residents in cardiovascular surgery.<\/div>
![\"Huy](\"https:\/\/med.virginia.edu\/tcv-lab\/wp-content\/uploads\/sites\/460\/2019\/03\/Ta_2019.jpg\")
<\/div>![\"Cindy](\"https:\/\/med.virginia.edu\/tcv-lab\/wp-content\/uploads\/sites\/460\/2023\/03\/Cindy2023_rec.jpg\")
<\/div>![\"Autumn](\"https:\/\/med.virginia.edu\/tcv-lab\/wp-content\/uploads\/sites\/460\/2022\/11\/Autumn_rec.jpg\")
<\/div>![\"Dustin](\"https:\/\/med.virginia.edu\/tcv-lab\/wp-content\/uploads\/sites\/460\/2018\/06\/Dustin_bio.jpg\")
<\/div>